APRIL Drives a Coordinated but Diverse Response as a Foundation for Plasma Cell Longevity

J Immunol. 2022 Sep 1;209(5):926-937. doi: 10.4049/jimmunol.2100623. Epub 2022 Aug 5.

Abstract

Ab-secreting cells survive in niche microenvironments, but cellular responses driven by particular niche signals are incompletely defined. The TNF superfamily member a proliferation-inducing ligand (APRIL) can support the maturation of transitory plasmablasts into long-lived plasma cells. In this study, we explore the biological programs established by APRIL in human plasmablasts. Under conditions allowing the maturation of ex vivo- or in vitro-generated plasmablasts, we find that APRIL drives activation of ERK, p38, and JNK, accompanied by a classical NF-κB response and activation of the AKT/FOXO1 pathway. Time-course gene expression data resolve coordinated transcriptional responses propagated via immediate early genes and NF-κB targets and converging onto modules of genes enriched for MYC targets and metabolism/cell growth-related pathways. This response is shared between APRIL and an alternate TNF superfamily member CD40L but is not a feature of alternative niche signals delivered by IFN-α or SDF1. However, APRIL and CD40L responses also diverge. CD40L drives expression of genes related to the activated B cell state whereas APRIL does not. Thus, APRIL establishes a broad foundation for plasma cell longevity with features of cellular refueling while being uncoupled from support of the B cell state.

MeSH terms

  • CD40 Ligand*
  • Humans
  • NF-kappa B* / metabolism
  • Plasma Cells / metabolism
  • Proto-Oncogene Proteins c-akt
  • Tumor Necrosis Factor Ligand Superfamily Member 13

Substances

  • NF-kappa B
  • TNFSF13 protein, human
  • Tumor Necrosis Factor Ligand Superfamily Member 13
  • CD40 Ligand
  • Proto-Oncogene Proteins c-akt